|
Pre-Congress Courses
Register for the course of your choice on the
Pre-Congress Courses Registration page.
Date: Saturday April 21
Time: 08:00 - 17:00
Chairs: Giuseppe Remuzzi, Italy
Roland Blantz, USA
Program
| 08:00 - 08:45 |
Lecture: Race, Environment and Familial Clustering as Factors Contributing to Chronic Kidney Disease
Neil Powe, USA |
| |
Roundtable 1: The Cardio-Renal Syndrome
Chair: Roland Blantz, USA |
| 08:45 - 09:05 |
Microalbuminuria, Renal Disease and the Insulin Resistance Syndrome
Carl-Erik Mogensen, Denmark |
| 09:05 - 09:25 |
Renal Insufficiency and Cardiac Dysfunction: Which Comes First?
Patrick Parfrey, Canada |
| 09:25 - 09:45 |
Cardioprotection in Chronic Kidney Disease: Which Target?
Jonathan Himmelfarb, USA |
| 09:45 - 10:05 |
Lessons Learned from the Operation of a Chronic Kidney Disease Clinic. Are the Outcomes Beneficial to Patients?
Adeera Levin, Canada |
| 10:05 - 10:25 |
Genetic Factors in Diabetic Nephropathy
Barry I. Freedman, USA |
| |
Roundtable 2: Anemia and Progression of Renal and Cardiovascular Disease
Chair: Ajay K. Singh, UK |
| 10:25 - 10:45 |
Does the Anemia of CKD Contribute to Renal Disease Progression?
Jerome Rossert, France |
| 10:45 - 11:05 |
Anemia as an Independent Cardiovascular Risk Factor in Chronic Kidney Disease
Ajay K. Singh, UK |
| 11:05 - 11:25 |
Anemia Management in Chronic Kidney Disease and Beyond
Robert Brenner, USA |
| |
|
| 11:25 - 12:10 |
Lecture: Genetic Contributions to Likelihood and Progression of CKD
John R. Sedor, USA |
| |
|
| 12:10 - 13: 00 |
Lunch |
| |
|
Roundtable 3: Blood Pressure: the Lower is Fine?
Chair: Roland Blantz, USA |
| 13:00 - 13:20 |
Factors Contributing to Nephron Number and Development of Hypertension and Progressive Kidney Disease
John Bertram, Australia |
| 13:20 - 13:40 |
Nitric Oxide, Hypertension, Kidney Disease Progression and Cardiovascular Outcomes
Christine Baylis, USA |
| 13:40 - 14:00 |
Antihypertensive Therapy in Cardio-Renal Disease: Which Target and Which Drug?
Piero Ruggenenti, Italy |
| |
|
Roundtable 4: Albuminuria: a Marker or a Target?
Chair: Giuseppe Remuzzi, Italy |
| 14:00 - 14:20 |
Glomerular and Tubular Handling of Albumin
Andrea Remuzzi, Italy |
| 14:20 - 14:40 |
Albuminuria and Mechanisms of Vascular and Kidney Disease Progression
Roland Blantz, USA |
| 14:40 - 15:00 |
Glomerular Hyperfiltration and the Salt Paradox in Early Diabetes Mellitus: a Tubulo-Centric Vew
Volker Vallon, Germany |
| 15:00 - 15:20 |
Including Albuminuria as a Target in Therapy Guidelines?
David G. Warnock, USA |
| |
|
| 15:20 - 15:40 |
Lecture: Regression of Renal Lesions: Still a Dream for Humans?
Giuseppe Remuzzi, Italy |
Back to top
Date: Saturday April 21
Time: 08:30 - 17:00
Chairs: Dick de Zeeuw, The Netherlands
Ron Gansevoort, The Netherlands
Program
| 08:30 – 09:00 | Key Principles of Clinical Research
Ron Gansevoort, The Netherlands |
| 09:00 – 10:00 |
Cross-Sectional Studies
How common is kidney disease?
Ana Maria Cusumano, Argentina
Are rates of ESRD really changing?
Allan Collins, USA |
| 10:00 – 10:30 |
Case-Control Studies
Does Analgesic nephropathy still exist?
Bill Bennett, USA |
| 10:30 – 10:45 |
Discussion |
| 10:45 – 11:00 |
Coffee Break |
| 11:00 – 12:00 |
Cohort Studies
Does microalbuminuria predict subsequent renal and cardiovascular risk?
Ron Gansevoort, The Netherlands
Predictors of renal function decline.
Glenn Chertow, USA |
| 12:00 – 12:15 |
Discussion |
| 12:15 – 13:30 |
Lunch |
| 13:30 – 15:00 |
Randomized Controlled Trials
Proteinuria is more important than blood pressure.
Dick de Zeeuw, The Netherlands
Is a negative renal study really negative?
Martin Landray, UK
What is the optimal target hemoglobin in CKD and ESRD?
Kai-Uwe Eckardt, Germany |
| 15:00 – 15:15 |
Discussion |
| 15:15 – 15:30 |
Tea Break |
| 16:00 – 16:30 |
Meta-Analysis
ACE-I/ARB, is there renal benefit beyond blood pressure control?
Eberhard Ritz, Germany |
| 16:30 – 17:00 |
Conclusions
Dick de Zeeuw, The Netherlands
Ron Gansevoort, The Netherlands |
Back to top
Date: Saturday April 21
Time: 09:00 - 14:00
Chair: Philip O’Connell, Australia
Program
| 09:00 – 10:00 | Session 1: Medical Complications Following Renal Transplantation
Elias David-Neto, Brazil |
| 10:00 – 11:00 |
Session 2: Difficult Clinical Issues: Immunosuppression and Hepatitis
Adel Bakr, USA |
| 11:00 – 12:00 |
Break |
| 12:00 – 13:00 |
Session 3: How to Handle BK Nephropathy
Emilio Ramos, USA |
| 13:00 – 14:00 |
Session 4: Long-term Complications: Chronic Allograft Nephropathy and Neoplasia
Anil Chandraker, Australia |
Back to top
Date: Saturday April 21
Time: 07:30 - 17:00
Chair: Thomas Coffman, USA
Co-Chairs: Barbara Ballermann, Canada
Enyu Imai, Japan
Richard Kitching, Australia
Jing Zhou, USA
Program
Session 1: Genetics and Development
Chair: Jing Zhou, USA
Approaches to disease gene identification
Peter Harris, USA
Approaches to study kidney development
Jordan Kreidberg, USA
From genes to disease mechanisms
Jing Zhou, USA
Session 2: Molecular Physiology
Chair: Enyu Imai, Japan
Molecular physiology of the macula densa
Darwin Bell, USA
Applications of SiRNA in the kidney
Enyu Imai, Japan
Hypertension studies in genetically engineered mice
Thomas Coffman, USA
Molecular mechanisms of renal fibrosis
Raghu Kalluri, USA
Session 3: Immunology
Chair: Richard Kitching, Australia
Immune Mechanisms in Glomerulonephritis
David Salant, USA
Systemic autoimmunity and the kidney
Alan Salama, UK
Ischemia reperfusion and the kidney: linking ischemia, inflammation and allograft rejection
Hamid Rabb, USA
Progress towards allograft tolerance: will we ever get there?
Toby Coates, Australia
Session 4: Vascular Biology
Chair: Barbara Ballermann, Canada
Vascular injury as a consequence of oxidative stress
Christopher Wilcox, USA
Uric acid - fructose - NO and the metabolic syndrome
Richard Johnson, USA
Why the interaction of complement factor H with glomerular endothelium is so important
Richard Quigg, USA
Endothelial cell progenitors
Back to top
|
